Chandan Healthcare Ltd Shows Technical Momentum Shift Amid Mixed Returns

Technical Momentum Shift and Price Action

On 10 July 2026, Chandan Healthcare Ltd’s stock closed at ₹254.10, up 4.96% from the previous close of ₹242.10. The intraday range was relatively tight, with a low of ₹246.25 and a high of ₹255.85. This price movement indicates a strengthening buying interest after a period of subdued performance. The stock remains well below its 52-week high of ₹358.00 but comfortably above its 52-week low of ₹185.40, suggesting room for recovery within its trading range.

The recent technical trend upgrade from mildly bearish to mildly bullish is supported by weekly MACD readings, which have turned positive, signalling increasing upward momentum. The Bollinger Bands on the weekly chart also show a bullish expansion, indicating rising volatility with an upward bias. Meanwhile, the daily moving averages remain mildly bearish, reflecting some short-term caution among traders.

Technical Indicator Analysis

The Moving Average Convergence Divergence (MACD) on the weekly timeframe has improved to a mildly bullish stance, suggesting that the stock’s short-term momentum is gaining strength relative to its longer-term trend. However, the monthly MACD remains neutral, indicating that the longer-term trend has yet to confirm a sustained uptrend.

The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in a neutral zone. This implies that the stock is neither overbought nor oversold, leaving room for further directional movement without immediate risk of reversal due to extreme conditions.

Bollinger Bands on the weekly chart have expanded with the price moving towards the upper band, a classic bullish sign that often precedes continued upward price action. This contrasts with the monthly Bollinger Bands, which remain neutral, reinforcing the notion that the longer-term trend is still consolidating.

Other momentum indicators such as the Know Sure Thing (KST) and Dow Theory signals on the weekly chart have also turned mildly bullish, reinforcing the positive momentum shift. The monthly Dow Theory remains mildly bullish as well, suggesting that the broader trend may be gradually improving.

On-Balance Volume (OBV) readings on the weekly chart show a mildly bullish trend, indicating that volume is supporting the price gains. However, the monthly OBV shows no clear trend, signalling that longer-term accumulation or distribution remains uncertain.

Mojo Score and Grade Implications

Chandan Healthcare Ltd currently holds a Mojo Score of 45.0, placing it in the Sell category with a Mojo Grade of Sell as of 7 July 2026. This represents a downgrade from its previous Hold rating, reflecting concerns over the company’s fundamentals or market positioning despite the recent technical improvements. The downgrade to Sell is significant for investors, especially given the company’s micro-cap status, which often entails higher volatility and risk.

Investors should weigh the technical momentum gains against the fundamental caution signalled by the Mojo Grade. The hospital sector, in which Chandan Healthcare operates, remains competitive and sensitive to regulatory and operational challenges, which may explain the cautious stance.

Comparative Performance Versus Sensex

Examining Chandan Healthcare’s returns relative to the Sensex provides further context. Over the past week, the stock has outperformed the benchmark with a 1.64% gain compared to the Sensex’s 0.88% decline. Over the last month, the stock’s return of 7.1% significantly exceeds the Sensex’s 3.10% rise, indicating short-term strength.

However, year-to-date (YTD) performance remains weak, with the stock down 21.71% versus the Sensex’s 8.29% decline. Over the past year, the stock has rebounded strongly with a 19.97% gain, outperforming the Sensex’s negative 5.94% return. Longer-term data for three, five, and ten years is not available for the stock, but the Sensex’s robust gains over these periods highlight the challenges faced by this micro-cap in sustaining growth.

Moving Averages and Short-Term Outlook

Daily moving averages for Chandan Healthcare remain mildly bearish, indicating that short-term price action is still under some pressure. This suggests that while weekly and monthly indicators are improving, traders should remain cautious in the near term. A sustained break above key moving averages would be required to confirm a stronger bullish trend.

The mixed signals from different timeframes highlight the importance of monitoring multiple technical indicators before making investment decisions. The mildly bullish weekly and monthly signals suggest a potential recovery phase, but the daily bearish moving averages caution against premature optimism.

Investor Takeaway

Chandan Healthcare Ltd’s recent technical upgrades suggest a cautiously optimistic outlook for the stock. The shift to mildly bullish momentum on weekly and monthly indicators, supported by positive MACD and Bollinger Band signals, indicates that the stock may be entering a recovery phase. However, the daily moving averages and the Mojo Grade downgrade to Sell highlight ongoing risks and the need for careful monitoring.

Investors should consider the stock’s micro-cap nature, which typically entails higher volatility and liquidity constraints. The company’s performance relative to the Sensex shows mixed results, with short-term outperformance but significant YTD weakness. This underscores the importance of a balanced approach that weighs technical signals alongside fundamental and sectoral factors.

For those considering exposure to the hospital sector, it may be prudent to compare Chandan Healthcare Ltd with other top-rated alternatives that offer stronger fundamental and technical profiles. The evolving technical landscape for Chandan Healthcare warrants close attention, particularly if the stock can sustain gains above key moving averages and confirm bullish momentum on longer-term charts.

Conclusion

In summary, Chandan Healthcare Ltd is showing early signs of a technical turnaround, with momentum indicators improving from a mildly bearish to a mildly bullish stance. While this is encouraging, the downgrade in Mojo Grade and mixed signals from daily moving averages suggest that investors should remain cautious. Monitoring the stock’s ability to maintain upward momentum and comparing it with better-rated peers will be essential for making informed investment decisions in this micro-cap hospital sector stock.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today